China Pharma Holdings
CPHI
5 hedge funds and large institutions have $118K invested in China Pharma Holdings in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1.79% less ownership
Funds ownership: 3.64% → 1.85% (-1.8%)
44% less capital invested
Capital invested by funds: $212K → $118K (-$94K)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$18K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12.5K |
| 3 |
JP Morgan Chase
New York
|
+$68 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$88.4K |
| 2 |
HF
HRT Financial
New York
|
-$28K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $59.3K | +$12.5K | +7,356 | +32% |
|
|
2
UBS Group
Zurich,
Switzerland
| $37.4K | -$88.4K | -52,042 | -73% |
|
|
3
Renaissance Technologies
New York
| $20.7K | +$18K | +10,618 | New |
|
|
4
JP Morgan Chase
New York
| $78 | +$68 | +40 | New |
|
|
DB
5
Danske Bank
Copenhagen K,
Denmark
| $2 | – | – | – |
|
|
HF
6
HRT Financial
New York
| – | -$28K | -16,168 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$14.7K | -8,213 | Closed |
|
CPHI Hedge Fund Activity: Q3 2025 in Review
5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2025, worth a combined $118K — down 44% from $212K a quarter earlier.
Fund positioning in CPHI was balanced in Q3 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $18K. The largest seller was UBS Group, cutting an estimated $88.4K.
- 5 institutional investors held China Pharma Holdings (CPHI) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $118K of China Pharma Holdings stock for Q3 2025, down 44% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q3 2025 and 2 closed out, a net change of 0 holders.
- The largest China Pharma Holdings buyer in Q3 2025 was Renaissance Technologies, an estimated $18K added.
- The largest China Pharma Holdings seller in Q3 2025 was UBS Group, an estimated $88.4K sold.
Based on aggregated 13F filings for Q3 2025.